Therapeutic and Adverse Effects of Standard-Dose and Low-Dose Meglumine Antimoniate During Systemic Treatment of Syrian Cutaneous Leishmaniasis Patients. J Pak Assoc Dermatol 2016, 24 (2), 115-121. https://doi.org/10.66344/jpad.v24i2.189.